BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
Healthcare
Bryan, Garnier & Co advised a hyperbaric oxygen therapy company on its sale to Candescent Partners.
Bryan, Garnier & Co advises Mérieux Alliance for the divestiture of ShanH (the majority shareholder of the Indian vaccine company Shantha Biotechnics) to Sanofi-aventis
Bryan, Garnier & Co has successfully advised majority shareholder GRED in the public tender offer & squeeze out of Softway Medical
Bryan, Garnier & Co. announces it has advised ExonHit Therapeutics on the free allocation of subscription warrants to all its shareholders
Bryan, Garnier & Co. announces successful admission of ONI BioPharma Inc.’s common stock to listing and trading on NYSE Alternext Paris
Bryan, Garnier & Co successfully advised Pierrel on its EUR 17.1 million follow-on offering
Bryan Garnier successfully leads €12 million IPO for Ipsogen
Bryan, Garnier & Co. successfully completes the placement of the international tranche of Arkimedica’s € 28 million convertible bond
Bryan, Garnier & Co advised Plethico Pharmaceuticals Limited on its acquisition of Natrol, Inc.
Bryan, Garnier & Co successfully leads a €40 million private placement in public equity for BioAlliance
1
…
15
16
17
18
Privacy Preference Center
Privacy Preferences